EGFR and neoplasm: More interestingly, no difference of tumor volume was detected between shEGFR-2-T24 untreated group and shEGFR-2-T24 proguanil-treated groups, indicating the critical role of EGFR in inhibitory effect of proguanil (Fig. 8A, B).